Advaxis, Inc. (NASDAQ: ADXS) gains 10% early after the company announced that Advaxis has granted a license to OS Therapies ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE